Effect of Cognitive Behavioral Therapy for Insomnia on Insomnia Symptoms for Individuals With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial

Mohammed M Alshehri, Aqeel M Alenazi, Jeffrey C Hoover, Shaima A Alothman, Milind A Phadnis, Jason L Rucker, Christie A Befort, John M Miles, Patricia M Kluding, Catherine F Siengsukon, Mohammed M Alshehri, Aqeel M Alenazi, Jeffrey C Hoover, Shaima A Alothman, Milind A Phadnis, Jason L Rucker, Christie A Befort, John M Miles, Patricia M Kluding, Catherine F Siengsukon

Abstract

Background: Insomnia symptoms are a common form of sleep difficulty among people with type 2 diabetes (T2D) affecting sleep quality and health outcomes. Several interventional approaches have been used to improve sleep outcomes in people with T2D. Nonpharmacological approaches, such as cognitive behavioral therapy for insomnia (CBT-I), show promising results regarding safety and sustainability of improvements, although CBT-I has not been examined in people with T2D. Promoting sleep for people with insomnia and T2D could improve insomnia severity and diabetes outcomes.

Objective: The objective of this study is to establish a protocol for a pilot randomized controlled trial (RCT) to examine the effect of 6 sessions of CBT-I on insomnia severity (primary outcome), sleep variability, and other health-related outcomes in individuals with T2D and insomnia symptoms.

Methods: This RCT will use random mixed block size randomization with stratification to assign 28 participants with T2D and insomnia symptoms to either a CBT-I group or a health education group. Outcomes including insomnia severity; sleep variability; diabetes self-care behavior (DSCB); glycemic control (A1c); glucose level; sleep quality; daytime sleepiness; and symptoms of depression, anxiety, and pain will be gathered before and after the 6-week intervention. Chi-square and independent t tests will be used to test for between-group differences at baseline. Independent t tests will be used to examine the effect of the CBT-I intervention on change score means for insomnia severity, sleep variability, DSCB, A1c, fatigue, sleep quality, daytime sleepiness, and severity of depression, anxiety, and pain. For all analyses, alpha level will be set at .05.

Results: This study recruitment began in February 2019 and was completed in September 2019.

Conclusions: The intervention, including 6 sessions of CBT-I, will provide insight about its effect in improving insomnia symptoms, sleep variability, fatigue, and diabetes-related health outcomes in people with T2D and those with insomnia symptoms when compared with control.

Trial registration: ClinicalTrials.gov NCT03713996; https://ichgcp.net/clinical-trials-registry/NCT03713996.

International registered report identifier (irrid): DERR1-10.2196/14647.

Keywords: cognitive behavioral therapy; fatigue; insomnia; self-care; sleep variability; type 2 diabetes.

Conflict of interest statement

Conflicts of Interest: None declared.

©Mohammed M Alshehri, Aqeel M Alenazi, Jeffrey C Hoover, Shaima A Alothman, Milind A Phadnis, Jason L Rucker, Christie A Befort, John M Miles, Patricia M Kluding, Catherine F Siengsukon. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 19.12.2019.

Figures

Figure 1
Figure 1
The timeline of the CBT-I (cognitive behavioral therapy for insomnia) intervention.
Figure 2
Figure 2
The timeline of Health Education.
Figure 3
Figure 3
Consort of the project. A1c: glycemic control; BDI: Beck Depression Inventory; BPI: Brief Pain Inventory; CBT-I: cognitive behavioral therapy for insomnia; DCP: diabetic care profile DSCB: diabetes self-care behavior; ESS: Epworth Sleepiness Scale; GAD-7: Generalized Anxiety Disorder–7; ISI: Insomnia Severity Index; PSQI: Pittsburgh Sleep Quality Index; and T2D: type 2 diabetes.

References

    1. Strand LB, Carnethon M, Biggs ML, Djoussé L, Kaplan RC, Siscovick DS, Robbins JA, Redline S, Patel SR, Janszky I, Mukamal KJ. Sleep disturbances and glucose metabolism in older adults: the cardiovascular health study. Diabetes Care. 2015 Nov;38(11):2050–8. doi: 10.2337/dc15-0137.
    1. Sinclair A, Dunning T, Rodriguez-Mañas L. Diabetes in older people: new insights and remaining challenges. Lancet Diabetes Endocrinol. 2015 Apr;3(4):275–85. doi: 10.1016/S2213-8587(14)70176-7.
    1. American Diabetes Association 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019 Jan;42(Suppl 1):S13–28. doi: 10.2337/dc19-S002.
    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014 Jan;37(Suppl 1):S81–90. doi: 10.2337/dc14-S081.
    1. Chauhan A, Sharma SD. Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab. 2016;20(6):881–2. doi: 10.4103/2230-8210.192910.
    1. Surani S, Brito V, Surani A, Ghamande S. Effect of diabetes mellitus on sleep quality. World J Diabetes. 2015 Jun 25;6(6):868–73. doi: 10.4239/wjd.v6.i6.868.
    1. Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab. 2005 May;90(5):3106–14. doi: 10.1210/jc.2004-1056.
    1. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study. Diabetes Care. 2009 Nov;32(11):1980–5. doi: 10.2337/dc09-0284.
    1. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M, Fernández-Mendoza J, Bixler EO. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep. 2010 Sep;33(9):1159–64. doi: 10.1093/sleep/33.9.1159.
    1. Balbo M, Leproult R, Van Cauter E. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int J Endocrinol. 2010;2010:759234. doi: 10.1155/2010/759234. doi: 10.1155/2010/759234.
    1. Chasens ER, Umlauf MG. Nocturia: a problem that disrupts sleep and predicts obstructive sleep apnea. Geriatr Nurs. 2003;24(2):76–81, 105. doi: 10.1067/mgn.2003.27.
    1. Umlauf MG, Chasens ER. Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev. 2003 Oct;7(5):403–11.
    1. Balbo M, Leproult R, Van Cauter E. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int J Endocrinol. 2010;2010:759234. doi: 10.1155/2010/759234. doi: 10.1155/2010/759234.
    1. Martins RC, Andersen ML, Tufik S. The reciprocal interaction between sleep and type 2 diabetes mellitus: facts and perspectives. Braz J Med Biol Res. 2008 Mar;41(3):180–7. doi: 10.1590/s0100-879x2006005000194.
    1. Budhiraja R, Roth T, Hudgel DW, Budhiraja P, Drake CL. Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep. 2011 Jul 1;34(7):859–67. doi: 10.5665/SLEEP.1114.
    1. Chasens ER, Sereika SM, Burke LE, Strollo PJ, Korytkowski M. Sleep, health-related quality of life, and functional outcomes in adults with diabetes. Appl Nurs Res. 2014 Nov;27(4):237–41. doi: 10.1016/j.apnr.2014.02.006.
    1. Skomro RP, Ludwig S, Salamon E, Kryger MH. Sleep complaints and restless legs syndrome in adult type 2 diabetics. Sleep Med. 2001 Sep;2(5):417–22.
    1. Ahmad S, Gupta M, Gupta R, Dhyani M. Prevalence and correlates of insomnia and obstructive sleep apnea in chronic kidney disease. N Am J Med Sci. 2013 Nov;5(11):641–6. doi: 10.4103/1947-2714.122306.
    1. Kamel NS, Gammack JK. Insomnia in the elderly: cause, approach, and treatment. Am J Med. 2006 Jun;119(6):463–9. doi: 10.1016/j.amjmed.2005.10.051.
    1. Hajak G, SINE Study Group. Study of Insomnia in Europe Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci. 2001;251(2):49–56.
    1. Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF. Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2014 Jan;21(1):57–64. doi: 10.1177/2047487312460020.
    1. Laugsand LE, Vatten LJ, Platou C, Janszky I. Insomnia and the risk of acute myocardial infarction: a population study. Circulation. 2011 Nov 8;124(19):2073–81. doi: 10.1161/CIRCULATIONAHA.111.025858.
    1. Sivertsen B, Pallesen S, Glozier N, Bjorvatn B, Salo P, Tell GS, Ursin R, Øverland S. Midlife insomnia and subsequent mortality: the Hordaland health study. BMC Public Health. 2014 Jul 15;14:720. doi: 10.1186/1471-2458-14-720.
    1. Chasens ER, Korytkowski M, Sereika SM, Burke LE. Effect of poor sleep quality and excessive daytime sleepiness on factors associated with diabetes self-management. Diabetes Educ. 2013;39(1):74–82. doi: 10.1177/0145721712467683.
    1. Williams GC, McGregor HA, Zeldman A, Freedman ZR, Deci EL. Testing a self-determination theory process model for promoting glycemic control through diabetes self-management. Health Psychol. 2004 Jan;23(1):58–66. doi: 10.1037/0278-6133.23.1.58.
    1. Pilcher JJ, Ginter DR, Sadowsky B. Sleep quality versus sleep quantity: relationships between sleep and measures of health, well-being and sleepiness in college students. J Psychosom Res. 1997 Jun;42(6):583–96. doi: 10.1016/s0022-3999(97)00004-4.
    1. Lemola S, Ledermann T, Friedman EM. Variability of sleep duration is related to subjective sleep quality and subjective well-being: an actigraphy study. PLoS One. 2013;8(8):e71292. doi: 10.1371/journal.pone.0071292.
    1. Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, Smith PL, Schwartz AR, Redline S, Pack AI, Dinges DF. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997 Oct;20(10):835–43.
    1. Altevogt BM, Colten HR, Institute of Medicine. Board on Health Sciences Policy. Committee on Sleep Medicine and Research . Sleep Disorders And Sleep Deprivation: An Unmet Public Health Problem. Washington DC: National Academies Press; 2006.
    1. Luyster FS, Dunbar-Jacob J. Sleep quality and quality of life in adults with type 2 diabetes. Diabetes Educ. 2011;37(3):347–55. doi: 10.1177/0145721711400663.
    1. Molzof HE, Emert SE, Tutek J, Mulla MM, Lichstein KL, Taylor DJ, Riedel BW. Intraindividual sleep variability and its association with insomnia identity and poor sleep. Sleep Med. 2018 Dec;52:58–66. doi: 10.1016/j.sleep.2018.08.014.
    1. Patel SR, Hayes AL, Blackwell T, Evans DS, Ancoli-Israel S, Wing YK, Stone KL, Osteoporotic Fractures in Men (MrOS) Study of Osteoporotic Fractures (SOF) Research Groups The association between sleep patterns and obesity in older adults. Int J Obes (Lond) 2014 Sep;38(9):1159–64. doi: 10.1038/ijo.2014.13.
    1. Luik AI, Zuurbier LA, Hofman A, van Someren EJ, Tiemeier H. Stability and fragmentation of the activity rhythm across the sleep-wake cycle: the importance of age, lifestyle, and mental health. Chronobiol Int. 2013 Dec;30(10):1223–30. doi: 10.3109/07420528.2013.813528.
    1. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009 Sep 15;78(6):539–52. doi: 10.1016/j.bcp.2009.04.029.
    1. Vgontzas AN, Bixler EO, Basta M. Obesity and sleep: a bidirectional association? Sleep. 2010 May;33(5):573–4. doi: 10.1093/sleep/33.5.573.
    1. Taylor DJ, Lichstein KL, Durrence HH, Reidel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005 Nov;28(11):1457–64. doi: 10.1093/sleep/28.11.1457.
    1. Aikens JE, Perkins DW, Lipton B, Piette JD. Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes. Diabetes Care. 2009 Jul;32(7):1177–81. doi: 10.2337/dc09-0071.
    1. Spiegel K, Knutson K, Leproult R, Tasali E, van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol (1985) 2005 Nov;99(5):2008–19. doi: 10.1152/japplphysiol.00660.2005.
    1. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002 Feb;59(2):131–6. doi: 10.1001/archpsyc.59.2.131.
    1. Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD, Garfinkel L. Mortality hazard associated with prescription hypnotics. Biol Psychiatry. 1998 May 1;43(9):687–93. doi: 10.1016/s0006-3223(97)00292-8.
    1. Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M. A systematic review of research examining benzodiazepine-related mortality. Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):93–103. doi: 10.1002/pds.1694.
    1. Hublin C, Partinen M, Koskenvuo M, Kaprio J. Sleep and mortality: a population-based 22-year follow-up study. Sleep. 2007 Oct;30(10):1245–53. doi: 10.1093/sleep/30.10.1245.
    1. Weich S, Pearce HL, Croft P, Singh S, Crome I, Bashford J, Frisher M. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. Br Med J. 2014 Mar 19;348:g1996. doi: 10.1136/bmj.g1996.
    1. Sivertsen B, Madsen IE, Salo P, Tell GS, Øverland S. Use of sleep medications and mortality: the Hordaland health study. Drugs Real World Outcomes. 2015 Jun;2(2):123–8. doi: 10.1007/s40801-015-0023-8.
    1. Ambrose AF, Paul G, Hausdorff JM. Risk factors for falls among older adults: a review of the literature. Maturitas. 2013 May;75(1):51–61. doi: 10.1016/j.maturitas.2013.02.009.
    1. Yang Y, Lai J, Lee C, Wang J, Chen P. Increased risk of hospitalization related to motor vehicle accidents among people taking zolpidem: a case-crossover study. J Epidemiol. 2011;21(1):37–43. doi: 10.2188/jea.je20090195.
    1. Carlsten A, Waern M. Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr. 2009 Jun 4;9:20. doi: 10.1186/1471-2318-9-20.
    1. Lin C, Yeh M, Harnod T, Lin C, Kao C. Risk of type 2 diabetes in patients with nonapnea sleep disorders in using different types of hypnotics: a population-based retrospective cohort study. Medicine (Baltimore) 2015 Sep;94(38):e1621. doi: 10.1097/MD.0000000000001621. doi: 10.1097/MD.0000000000001621.
    1. Gramaglia E, Ramella Gigliardi V, Olivetti I, Tomelini M, Belcastro S, Calvi E, Dotta A, Ghigo E, Benso A, Broglio F. Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects. J Endocrinol Invest. 2014 Feb;37(2):203–6. doi: 10.1007/s40618-013-0016-y.
    1. Wang X, Bi Y, Zhang Q, Pan F. Obstructive sleep apnoea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Respirology. 2013 Jan;18(1):140–6. doi: 10.1111/j.1440-1843.2012.02267.x.
    1. Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res. 2016;5:918. doi: 10.12688/f1000research.8729.3.
    1. Weinstock TG, Wang X, Rueschman M, Ismail-Beigi F, Aylor J, Babineau DC, Mehra R, Redline S. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012 May 1;35(5):617–25B. doi: 10.5665/sleep.1816.
    1. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, Coleman J, Kapur V, Lee-Chiong T, Owens J, Pancer J, Swick T, American Academy of Sleep Medicine Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep. 2006 Nov;29(11):1415–9.
    1. Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med. 2015 Aug 4;163(3):191–204. doi: 10.7326/M14-2841.
    1. Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012 May 25;13:40. doi: 10.1186/1471-2296-13-40.
    1. Akerstedt T, Kecklund G, Ingre M, Lekander M, Axelsson J. Sleep homeostasis during repeated sleep restriction and recovery: support from EEG dynamics. Sleep. 2009 Feb;32(2):217–22. doi: 10.1093/sleep/32.2.217.
    1. Taub LM, Redeker NS. Sleep disorders, glucose regulation, and type 2 diabetes. Biol Res Nurs. 2008 Jan;9(3):231–43. doi: 10.1177/1099800407311016.
    1. Leproult R, Deliens G, Gilson M, Peigneux P. Beneficial impact of sleep extension on fasting insulin sensitivity in adults with habitual sleep restriction. Sleep. 2015 May 1;38(5):707–15. doi: 10.5665/sleep.4660.
    1. Surwit RS, van Tilburg MA, Zucker N, McCaskill CC, Parekh P, Feinglos MN, Edwards CL, Williams P, Lane JD. Stress management improves long-term glycemic control in type 2 diabetes. Diabetes Care. 2002 Jan;25(1):30–4. doi: 10.2337/diacare.25.1.30.
    1. Rosmond R. Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes? Med Sci Monit. 2003 Feb;9(2):RA35–9.
    1. Golden SH, Shah N, Naqibuddin M, Payne JL, Hill-Briggs F, Wand GS, Wang N, Langan S, Lyketsos C. The prevalence and specificity of depression diagnosis in a clinic-based population of adults with type 2 diabetes mellitus. Psychosomatics. 2017;58(1):28–37. doi: 10.1016/j.psym.2016.08.003.
    1. Schoicket SL, Bertelson AD, Lacks P. Is sleep hygiene a sufficient treatment for sleep-maintenance insomnia? Behav Ther. 1988;19(2):183–90. doi: 10.1016/s0005-7894(88)80041-8.
    1. Mobley DF, Baum N. Etiology, evaluation, and management of nocturia in elderly men and women. Postgrad Med. 2014 Mar;126(2):147–53. doi: 10.3810/pgm.2014.03.2751.
    1. Tyagi S, Resnick NM, Perera S, Monk TH, Hall MH, Buysse DJ. Behavioral treatment of insomnia: also effective for nocturia. J Am Geriatr Soc. 2014 Jan;62(1):54–60. doi: 10.1111/jgs.12609.
    1. Chan A, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200–7. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Schulz KF, Altman DG, Moher D, CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Br Med J. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.
    1. Alshehri MM. Clinical Trials. 2018. [2019-11-01]. The Effect of Cognitive Behavioral Therapy for Insomnia on Type 2 Diabetes Health Outcomes. .
    1. Shafazand S, Wallace DM, Vargas SS, Del Toro Y, Dib S, Abreu AR, Ramos A, Nolan B, Baldwin CM, Fleming L. Sleep disordered breathing, insomnia symptoms, and sleep quality in a clinical cohort of US Hispanics in south Florida. J Clin Sleep Med. 2012 Oct 15;8(5):507–14. doi: 10.5664/jcsm.2142. doi: 10.5664/jcsm.2142.
    1. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999 Oct 5;131(7):485–91. doi: 10.7326/0003-4819-131-7-199910050-00002.
    1. Pereira EJ, Driver HS, Stewart SC, Fitzpatrick MF. Comparing a combination of validated questionnaires and level III portable monitor with polysomnography to diagnose and exclude sleep apnea. J Clin Sleep Med. 2013 Dec 15;9(12):1259–66. doi: 10.5664/jcsm.3264. doi: 10.5664/jcsm.3264.
    1. Nagappa M, Liao P, Wong J, Auckley D, Ramachandran SK, Memtsoudis S, Mokhlesi B, Chung F. Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnea among different populations: a systematic review and meta-analysis. PLoS One. 2015;10(12):e0143697. doi: 10.1371/journal.pone.0143697.
    1. Garcia-Borreguero D, Stillman P, Benes H, Buschmann H, Chaudhuri KR, Rodríguez VM, Högl Birgit, Kohnen R, Monti GC, Stiasny-Kolster K, Trenkwalder C, Williams A, Zucconi M. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care. BMC Neurol. 2011 Feb 27;11:28. doi: 10.1186/1471-2377-11-28.
    1. Allen RP, Stillman P, Myers AJ. Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics. Sleep Med. 2010 Jan;11(1):31–7. doi: 10.1016/j.sleep.2009.03.007.
    1. Çoban A, Yanikkerem U. Sleep quality and fatigue in pregnant women. Ege Journal of Medicine. 2010;49(2):87–94.
    1. US Department of Health and Human Services. Public Health Service. National Institutes of Health. National Institute on Alcohol Abuse and Alcoholism Welcome to the MSU/COM Kobiljak Centers. [2019-11-01]. The Physicians' Guide to Helping Patients With Alcohol Problems. .
    1. Balsa AI, Homer JF, Fleming MF, French MT. Alcohol consumption and health among elders. Gerontologist. 2008 Oct;48(5):622–36. doi: 10.1093/geront/48.5.622.
    1. Ghajarzadeh M, Sahraian MA, Fateh R, Daneshmand A. Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis. Acta Med Iran. 2012;50(4):244–9.
    1. Kang DW, Lee CU, Lim HK. Role of sleep disturbance in the trajectory of alzheimer's disease. Clin Psychopharmacol Neurosci. 2017 May 31;15(2):89–99. doi: 10.9758/cpn.2017.15.2.89.
    1. Menza M, Dobkin RD, Marin H, Bienfait K. Sleep disturbances in Parkinson's disease. Mov Disord. 2010;25(Suppl 1):S117–22. doi: 10.1002/mds.22788.
    1. Wickwire EM, Williams SG, Roth T, Capaldi VF, Jaffe M, Moline M, Motamedi GK, Morgan GW, Mysliwiec V, Germain A, Pazdan RM, Ferziger R, Balkin TJ, MacDonald ME, Macek TA, Yochelson MR, Scharf SM, Lettieri CJ. Sleep, sleep disorders, and mild traumatic brain injury. What we know and what we need to know: findings from a national working group. Neurotherapeutics. 2016 Apr;13(2):403–17. doi: 10.1007/s13311-016-0429-3.
    1. Ferre A, Ribó M, Rodríguez-Luna D, Romero O, Sampol G, Molina CA, Álvarez-Sabin J. Strokes and their relationship with sleep and sleep disorders. Neurologia. 2013 Mar;28(2):103–18. doi: 10.1016/j.nrl.2010.09.016.
    1. Steinan MK, Scott J, Lagerberg TV, Melle I, Andreassen OA, Vaaler AE, Morken G. Sleep problems in bipolar disorders: more than just insomnia. Acta Psychiatr Scand. 2016 May;133(5):368–77. doi: 10.1111/acps.12523.
    1. Staniszewska A, Mąka A, Religioni U, Olejniczak D. Sleep disturbances among patients with epilepsy. Neuropsychiatr Dis Treat. 2017;13:1797–803. doi: 10.2147/NDT.S136868. doi: 10.2147/NDT.S136868.
    1. McCrae CS, Lichstein KL. Secondary insomnia: diagnostic challenges and intervention opportunities. Sleep Med Rev. 2001 Feb;5(1):47–61. doi: 10.1053/smrv.2000.0146.
    1. Jackson ML, Bruck D. Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review. J Clin Sleep Med. 2012 Dec 15;8(6):719–28. doi: 10.5664/jcsm.2276. doi: 10.5664/jcsm.2276.
    1. Nicassio PM, Moxham EG, Schuman CE, Gevirtz RN. The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain. 2002 Dec;100(3):271–9. doi: 10.1016/s0304-3959(02)00300-7.
    1. Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996 Dec;68(2-3):363–8. doi: 10.1016/s0304-3959(96)03226-5.
    1. Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996 Aug;23(8):1407–17.
    1. Edwards RR, Cahalan C, Calahan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol. 2011 Apr;7(4):216–24. doi: 10.1038/nrrheum.2011.2.
    1. Gislason T, Almqvist M. Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men. Acta Med Scand. 1987;221(5):475–81.
    1. Kim YG, Yoon DY, Kim JI, Chae CH, Hong YS, Yang CG, Kim JM, Jung KY, Kim JY. Effects of health on shift-work: general and psychological health, sleep, stress, quality of life. Korean J Occup Environ Med. 2002;14(3):247. doi: 10.35371/kjoem.2002.14.3.247.
    1. Atkinson TM, Mendoza TR, Sit L, Passik S, Scher HI, Cleeland C, Basch E. The Brief Pain Inventory and its 'pain at its worst in the last 24 hours' item: clinical trial endpoint considerations. Pain Med. 2010 Mar;11(3):337–46. doi: 10.1111/j.1526-4637.2009.00774.x.
    1. Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai K, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage. 2005 Oct;30(4):374–85. doi: 10.1016/j.jpainsymman.2005.04.009.
    1. Beck A, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996 Dec;67(3):588–97. doi: 10.1207/s15327752jpa6703_13.
    1. Morawetz D. Insomnia and depression: which comes first? Sleep Res Online. 2003;5(2):77–81.
    1. Cully JA, Teten AL. MIRECC / CoE Home - Veterans Affairs. 2008. [2019-11-01]. A Therapist's Guide to Brief Cognitive Behavioral Therapy. .
    1. Cunningham JE, Shapiro CM. Cognitive Behavioural Therapy for Insomnia (CBT-I) to treat depression: A systematic review. J Psychosom Res. 2018 Mar;106:1–12. doi: 10.1016/j.jpsychores.2017.12.012.
    1. Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, Herzberg PY. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008 Mar;46(3):266–74. doi: 10.1097/MLR.0b013e318160d093.
    1. Villarroel M, Vahratian A, Ward BW. Health care utilization among US adults with diagnosed diabetes, 2013. NCHS Data Brief. 2015 Feb;(183):1–8.
    1. Schneider ALC, Pankow JS, Heiss G, Selvin E. Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2012 Oct 15;176(8):738–43. doi: 10.1093/aje/kws156.
    1. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, Kempainen S, Simin L, Robinson JG, Safford MM, Tinker LT, Phillips LS, Women Health Initiative Investigators Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials. 2008;5(3):240–7. doi: 10.1177/1740774508091749.
    1. White CA. Cognitive behavioral principles in managing chronic disease. West J Med. 2001 Nov;175(5):338–42. doi: 10.1136/ewjm.175.5.338.
    1. Perlis M, Jungquist C, Smith MT, Posner D. Cognitive Behavioral Treatment Of Insomnia: A Session-by-Session Guide. New York: Springer; 2006.
    1. Edinger J. UNC School of Medicine. [2019-11-01]. Treatment manual: Cognitive-behavioral insomnia therapy. .
    1. Baglioni C, Spiegelhalder K, Lombardo C, Riemann D. Sleep and emotions: a focus on insomnia. Sleep Med Rev. 2010 Aug;14(4):227–38. doi: 10.1016/j.smrv.2009.10.007.
    1. Ong JC, Shapiro SL, Manber R. Combining mindfulness meditation with cognitive-behavior therapy for insomnia: a treatment-development study. Behav Ther. 2008 Jun;39(2):171–82. doi: 10.1016/j.beth.2007.07.002.
    1. Conrad A, Roth WT. Muscle relaxation therapy for anxiety disorders: it works but how? J Anxiety Disord. 2007;21(3):243–64. doi: 10.1016/j.janxdis.2006.08.001.
    1. Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601–8. doi: 10.1093/sleep/34.5.601.
    1. Seow LS, Abdin E, Chang S, Chong SA, Subramaniam M. Identifying the best sleep measure to screen clinical insomnia in a psychiatric population. Sleep Med. 2018 Jan;41:86–93. doi: 10.1016/j.sleep.2017.09.015.
    1. Lichstein KL, Stone KC, Donaldson J, Nau SD, Soeffing JP, Murray D, Lester KW, Aguillard RN. Actigraphy validation with insomnia. Sleep. 2006 Feb;29(2):232–9.
    1. Ancoli-Israel S, Martin JL, Blackwell T, Buenaver L, Liu L, Meltzer LJ, Sadeh A, Spira AP, Taylor DJ. The SBSM guide to actigraphy monitoring: clinical and research applications. Behav Sleep Med. 2015;13(Suppl 1):S4–38. doi: 10.1080/15402002.2015.1046356.
    1. Otte JL, Payne JK, Carpenter JS. Nighttime variability in wrist actigraphy. J Nurs Meas. 2011;19(2):105–14.
    1. Cole JC, Motivala SJ, Buysse DJ, Oxman MN, Levin MJ, Irwin MR. Validation of a 3-factor scoring model for the Pittsburgh sleep quality index in older adults. Sleep. 2006 Jan;29(1):112–6. doi: 10.1093/sleep/29.1.112.
    1. Fitzgerald JT, Anderson RM, Gruppen LD, Davis WK, Aman LC, Jacober SJ, Grunberger G. The reliability of the Diabetes Care Profile for African Americans. Eval Health Prof. 1998 Mar;21(1):52–65. doi: 10.1177/016327879802100103.
    1. Fitzgerald JT, Davis WK, Connell CM, Hess GE, Funnell MM, Hiss RG. Development and validation of the Diabetes Care Profile. Eval Health Prof. 1996 Jun;19(2):208–30. doi: 10.1177/016327879601900205.
    1. Sikaris K. The correlation of hemoglobin A1c to blood glucose. J Diabetes Sci Technol. 2009 May 1;3(3):429–38. doi: 10.1177/193229680900300305.
    1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998 Sep 12;352(9131):837–53.
    1. Bernstein R, Parkes JL, Goldy A, Brown D, Harrison B, Chu A, Pflug BK, Simmons DA, Pardo S, Bailey TS. A new test strip technology platform for self-monitoring of blood glucose. J Diabetes Sci Technol. 2013 Sep 1;7(5):1386–99. doi: 10.1177/193229681300700531.
    1. Singh R, Kluding PM. Fatigue and related factors in people with type 2 diabetes. Diabetes Educ. 2013;39(3):320–6. doi: 10.1177/0145721713479144.
    1. Zelman DC, Gore M, Dukes E, Tai K, Brandenburg N. Validation of a modified version of the Brief Pain Inventory for painful diabetic peripheral neuropathy. J Vasc Nurs. 2005 Sep;23(3):97–104. doi: 10.1016/j.jvn.2005.06.004.
    1. Strunk Kk, Lane Fc. The Beck Depression Inventory, Second Edition (BDI-II) Measurement and Evaluation in Counseling. 2016 Aug 11;78(2):074817561666401–498. doi: 10.1177/0748175616664010.
    1. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77–100. doi: 10.1016/0272-7358(88)90050-5.
    1. Kroenke K, Spitzer RL, Williams JB, Löwe B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345–59. doi: 10.1016/j.genhosppsych.2010.03.006.
    1. Manber R, Edinger JD, Gress JL, Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008 Apr;31(4):489–95. doi: 10.1093/sleep/31.4.489.
    1. Kim J, Shin W. How to do random allocation (randomization) Clin Orthop Surg. 2014 Mar;6(1):103–9. doi: 10.4055/cios.2014.6.1.103.
    1. Krefting D, Jansen C, Penzel T, Han F, Kantelhardt JW. Age and gender dependency of physiological networks in sleep. Physiol Meas. 2017 May;38(5):959–75. doi: 10.1088/1361-6579/aa614e.
    1. Unruh ML, Redline S, An M, Buysse DJ, Nieto FJ, Yeh J, Newman AB. Subjective and objective sleep quality and aging in the sleep heart health study. J Am Geriatr Soc. 2008 Jul;56(7):1218–27. doi: 10.1111/j.1532-5415.2008.01755.x.
    1. van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. J Am Med Assoc. 2000 Aug 16;284(7):861–8. doi: 10.1001/jama.284.7.861.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다